1.Progress in treatment of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
Jinshan ZHAN ; Xiuyun XUAN ; Juanmei CAO ; Fangqi CHEN ; Changzheng HUANG
Chinese Journal of Dermatology 2025;58(8):785-788
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis is a special type of dermatomyositis. It has characteristic clinical manifestations, mild myositis symptoms, and is prone to be accompanied by rapidly progressive interstitial lung disease, which indicates a poor prognosis. Its pathogenesis remains unclear, and may be related to genetic and environmental factors. This review summarizes progress in the treatment of anti-MDA5 antibody-positive dermatomyositis in recent years, in order to provide new ideas for its clinical treatment.
2.Progress in treatment of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
Jinshan ZHAN ; Xiuyun XUAN ; Juanmei CAO ; Fangqi CHEN ; Changzheng HUANG
Chinese Journal of Dermatology 2025;58(8):785-788
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis is a special type of dermatomyositis. It has characteristic clinical manifestations, mild myositis symptoms, and is prone to be accompanied by rapidly progressive interstitial lung disease, which indicates a poor prognosis. Its pathogenesis remains unclear, and may be related to genetic and environmental factors. This review summarizes progress in the treatment of anti-MDA5 antibody-positive dermatomyositis in recent years, in order to provide new ideas for its clinical treatment.
3.Recognition of medical staff in the oncology department about management of cancer related fatigue:a qualitative research
Li TIAN ; Fen WANG ; Mei XUE ; Juanmei CAO ; Qunying ZHOU ; Yiqun YANG ; Huiling LI
Chinese Journal of Practical Nursing 2015;(36):2756-2758
Objective To explore how medical staff in the oncology department understand management of cancer related fatigue (CRF), and explore what factors influencing the effective practice of CRF management. Methods Qualitative inquiry was adopted. Ten medical staffs in the oncology department were selected for in- depth interview. Generic analysis was applied to code, categorize and interpret the qualitative data. Results Participants believed that many factors influenced the CRF, which hadn′t been assessed as an independent symptom and lacked the systematic, effective and specific interventions. The medical staff, patients and their families neglecting the CRF management was the main barrier. Strengthening system construction and staff training was mentioned as major area which needed to be improved. Conclusions CRF management guideline should be formulated according to our national situations based on the clinical practices, besides, the training of correlated clinical knowledge and skills of medical staff should be strengthened and eventually promote the cancer patients′quality of life.

Result Analysis
Print
Save
E-mail